Mobile

This is a trial that is studying a new inhaled medicine, MDT-637, that is being researched for the treatment of a viral infection of the lungs that typically affects the young and the elderly (Respira...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001107-20

This is a trial that is studying a new inhaled medicine, MDT-637, that is being researched for the treatment of a viral infection of the lungs that typically affects the young and the elderly (Respiratory Syncytial Virus, RSV). Adult volunteers will be infected with RSV (the infection is typically mild in adults), half of these volunteers will be treated with MDT-637, and the other half will receive placebo which has no effect on RSV

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary efficacy objective and endpoint of the study is to evaluate the antiviral effect (as defined by reduction in AUC of viral load) of aerosolized MDT-637, in a manner which mimics the timing of the infection and potential treatment application in infants and children.

Critère d'inclusion

  • RSV Infection

Liens